These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24408067)

  • 1. Evaluation of the clinical utility of urocortin 1 in systolic heart failure.
    Yildirim E; Keles I; Cakmak HA; Cosansu K; Can G; Ikitimur B
    Kardiol Pol; 2014; 72(5):452-8. PubMed ID: 24408067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation of the clinical utility of urocortin 1 and adrenomedullin versus proBNP in systolic heart failure.
    Yıldırım E; Cengiz M; Yıldırım N; Aslan K; İpek E; Korkmaz AF; Ulusoy FR; Hatem E
    Anatol J Cardiol; 2017 Mar; 17(3):184-190. PubMed ID: 25868038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical value of B-type natriuretic peptide in the diagnosis of left heart failure].
    Zhao XY; Yang YJ; Zhang J; Dang AM; Ni XH; Huang J; Kang S; Ma WH; Zhao DY
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1165-9. PubMed ID: 16796855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
    J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma urocortin in human systolic heart failure.
    Ng LL; Loke IW; O'Brien RJ; Squire IB; Davies JE
    Clin Sci (Lond); 2004 Apr; 106(4):383-8. PubMed ID: 14651473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.
    Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM
    Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between thoracic fluid content and natriuretic peptide type B in patients with systolic heart failure.
    Balak W; Sinkiewicz W; Gilewski W; Karasek D; Błazejewski J; Dudziak J
    Kardiol Pol; 2009 Nov; 67(11):1220-5. PubMed ID: 20024849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct comparison of B-type natriuretic peptide and N-terminal pro-BNP for assessment of cardiac function in a large population of symptomatic patients.
    Park HJ; Baek SH; Jang SW; Kim DB; Shin DI; Shin WS; Kim PJ; Jung HB; Jung HO; Seung KB; Choi KB
    Int J Cardiol; 2010 Apr; 140(3):336-43. PubMed ID: 19147239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of brain natriuretic peptide after acute myocardial infarction.
    Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of N-terminal pro-B-type natriuretic peptide increase with exercise for predicting cardiovascular mortality in patients with heart failure.
    Koç M; Bozkurt A; Acartürk E; Sahin DY; Unal I
    Am J Cardiol; 2008 Apr; 101(8):1157-62. PubMed ID: 18394451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
    Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
    Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F
    Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung ultrasound for the evaluation of pulmonary congestion in outpatients: a comparison with clinical assessment, natriuretic peptides, and echocardiography.
    Miglioranza MH; Gargani L; Sant'Anna RT; Rover MM; Martins VM; Mantovani A; Weber C; Moraes MA; Feldman CJ; Kalil RA; Sicari R; Picano E; Leiria TL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1141-51. PubMed ID: 24094830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of proBNP1-108 testing for the risk stratification of patients with systolic heart failure.
    Gruson D; Lepoutre T; Ahn SA; Rousseau MF
    Peptides; 2013 Dec; 50():125-8. PubMed ID: 24140405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NT-pro-BNP predicts worsening renal function in patients with chronic systolic heart failure.
    Pfister R; Müller-Ehmsen J; Hagemeister J; Hellmich M; Erdmann E; Schneider CA
    Intern Med J; 2011 Jun; 41(6):467-72. PubMed ID: 20214692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
    Schou M; Gustafsson F; Kistorp CN; Corell P; Kjaer A; Hildebrandt PR
    Am J Cardiol; 2007 Nov; 100(10):1571-6. PubMed ID: 17996522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.